# Revocation of the Test for Mycoplasma
> **Food and Drug Administration** · Final rule. · Published 2020-08-21 · Effective 2020-09-21 · 85 FR 51635
## Document
- **Document number:** 2020-17085
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 85 FR 51635
- **CFR reference:** 21 CFR 610
- **Publication date:** 2020-08-21
- **Effective date:** 2020-09-21
- **HHS docket:** Docket No. FDA-2018-N-4757
## Abstract

The Food and Drug Administration (FDA, the Agency, or we) is issuing a final rule to remove the specified test for the presence of Mycoplasma for live virus vaccines and inactivated virus vaccines produced from in vitro living cell cultures. The rule is being finalized because the existing test for Mycoplasma is overly restrictive in that it identifies only one test method in detail to be used even though other methods also may be appropriate. More sensitive and specific methods exist and are currently being practiced, and removal of the specific method to test for Mycoplasma provides flexibility for accommodating new and evolving technology and capabilities without diminishing public health protections. This action is part of FDA's implementation of Executive Orders under which FDA is comprehensively reviewing existing regulations to identify opportunities for repeal, replacement, or modification that will result in meaningful burden reduction, while allowing the Agency to achieve our public health mission and fulfill statutory obligations.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2020/08/21/2020-17085/revocation-of-the-test-for-mycoplasma)
---
*AI Analytics · CC0 1.0*